Maria A Mendoza Mohammad H Alshaer Giovanni Roldan Jose Guillermo Castro David Ashkin Charles A Peloquin Catherine V Boulanger
10.1177/23259582221111077
J Int Assoc Provid AIDS Care
2022 Jan-Dec;21:23259582221111077.
hiv dolutegravir rifabutin tuberculosis
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36026587/
Antibiotics, Antitubercular / therapeutic use HIV Infections Rifabutin / therapeutic use Tuberculosis
Antibiotics, Antitubercular / therapeutic use HIV Infections Rifabutin / therapeutic use Tuberculosis Heterocyclic Compounds, 3-Ring Humans Oxazines Piperazines Prospective Studies Pyridones Retrospective Studies Antibiotics, Antitubercular Heterocyclic Compounds, 3-Ring Oxazines Piperazines Pyridones Rifabutin dolutegravir
PMC9421219
36026587
Effect of Rifabutin in Dolutegravir Dosing: A Case Series
2022